-
-
Replying to @St_Rev
This, from a comment, was potentially extremely interesting:https://www.statnews.com/2020/05/14/gilead-should-ditch-remdesivir-and-focus-on-its-simpler-safer-ancestor/ …
1 reply 4 retweets 10 likes -
Replying to @Meaningness
There's already a black market in GS-441524 to treat feline infectious peritonitis, a horrible lethal disease. I imagine that market just dried up.
1 reply 0 retweets 2 likes -
Replying to @St_Rev
Saw that, yeah… the remdesivir synthesis looks like a nightmare, whereas GS-441524 is apparently pretty easy. If it’s also more effective for covid…
1 reply 1 retweet 2 likes -
Replying to @Meaningness
Says something about a society built out of ubiquitously exploitable processes. Everything's frozen in place.
1 reply 2 retweets 3 likes -
Replying to @St_Rev
No one can do anything, because anyone can prevent anyone else from doing anything.
1 reply 2 retweets 7 likes -
Replying to @Meaningness @St_Rev
At this point there’s probably a lot more clinical safety data from remdesivir, over years and many many patients. That sort of thing might be very costly and slow to replicate, for not stellar performing drug might not be worth it.
2 replies 0 retweets 1 like
Yes, from the article, that seems to be exactly the issue.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.